Jul 3 |
Moderna’s mRNA influenza vaccine receives $176m boost
|
Jul 3 |
Moderna Stock (NASDAQ:MRNA): Next-Gen COVID-19 Vaccine Is More Than a Rehash
|
Jul 2 |
mRNA Technology Promises To Make A Long-Time Coming Turning Point In Cancer Treatment
|
Jul 2 |
COVID infections could be seeing a summer surge based on CDC data
|
Jul 2 |
Moderna, Pfizer-BioNTech COVID-19 Vaccine Patent Legal Battle Gets Mixed UK Ruling
|
Jul 2 |
The US will pay Moderna $176 million to develop an mRNA pandemic flu vaccine
|
Jul 2 |
Moderna Receives HHS Grant To Develop a Bird Flu Vaccine
|
Jul 2 |
Moderna gets US funding for bird flu vaccine development
|
Jul 2 |
Moderna wins $176M flu vaccine contract from U.S.
|
Jul 2 |
Moderna Receives Project Award through BARDA's Rapid Response Partnership Vehicle Consortium to Accelerate Development of mRNA-based Pandemic Influenza Vaccine
|